Date: 11/11/2025 Location: Other
Mastering ASCVD Risk Management: Spotlight on Lp(a) is a focused 90-minute online masterclass designed to equip general practitioners and primary care teams with practical, evidence-based strategies to address residual cardiovascular risk beyond LDL-cholesterol control. Despite advances in lipid management, many patients remain at high risk of atherosclerotic cardiovascular disease (ASCVD), particularly those with a family history or recurrent events despite optimal therapy. This program explores the emerging role of lipoprotein(a) [Lp(a)] - a genetically determined, independent risk factor affecting up to one in five Australians - and its contribution to myocardial infarction, stroke, and aortic valve disease. Faculty will provide guidance on when and how to test for Lp(a), interpret results, and integrate findings into everyday practice. Through concise presentations, case-based discussions, and Qandamp;A, participants will learn how to embed Lp(a) testing into routine workflows, identify patients requiring therapy intensification, and apply contemporary guideline-directed management. The session supports active learning, performance review, and outcome measurement, empowering clinicians to recognise residual risk earlier, make confident testing decisions, and coordinate care that improves long-term patient outcomes.
1.5 Educational activity hours
1.5 Performance review hours
5 Outcome measurement hours
Ethical practice
Professionalism
Culturally safe practice